We are live on ! Find out more
NVO

Novo Nordisk
NVO

1,146 hedge funds and large institutions have $22.1B invested in Novo Nordisk in 2023 Q1 according to their latest regulatory filings, with 175 funds opening new positions, 327 increasing their positions, 428 reducing their positions, and 54 closing their positions.

New
Increased
Maintained
Reduced
Closed

224% more first-time investments, than exits

New positions opened: 175 | Existing positions closed: 54

30% more call options, than puts

Call options by funds: $296M | Put options by funds: $228M

22% more funds holding in top 10

Funds holding in top 10: 46 → 56 (+10)

15% more capital invested

Capital invested by funds: $19.3B → $22.1B (+$2.84B)

9% more funds holding

Funds holding: 1,049 → 1,146 (+97)

0.07% less ownership

Funds ownership: 16.45% → 16.38% (-0.07%)

24% less repeat investments, than reductions

Existing positions increased: 327 | Existing positions reduced: 428

Holders
1,146
Holders Change
+97
Holders Change %
+9.25%
% of All Funds
18.26%
Holding in Top 10
56
Holding in Top 10 Change
+10
Holding in Top 10 Change %
+21.74%
% of All Funds
0.89%
New
175
Increased
327
Reduced
428
Closed
54
Calls
$296M
Puts
$228M
Net Calls
+$68.1M
Net Calls Change
-$41.4M

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$504M
2
Envestnet Asset Management
Envestnet Asset Management
Illinois
+$502M
3
Jennison Associates
Jennison Associates
New York
+$126M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$115M
5
N
Nuveen
North Carolina
+$66.2M

Top Sellers

Rank Fund Capital Flow
1
Capital International Investors
Capital International Investors
California
-$360M
2
Renaissance Technologies
Renaissance Technologies
New York
-$256M
3
Millennium Management
Millennium Management
New York
-$216M
4
Fisher Asset Management
Fisher Asset Management
Washington
-$163M
5
Morgan Stanley
Morgan Stanley
New York
-$86.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
TAIM
826
TD Ameritrade Investment Management
Nebraska
$324K -$20.3K -286 -7%
PA
827
Procyon Advisors
Connecticut
$322K +$287K +4,052 New
TIA
828
Tiemann Investment Advisors
California
$322K – – –
GW
829
GW & Wade
Massachusetts
$322K +$31.2K +440 +12%
WA1
830
Wimmer Associates 1
California
$322K – – –
CWM
831
Cornerstone Wealth Management
Missouri
$322K +$287K +4,046 New
LWM
832
LJI Wealth Management
Indiana
$321K – – –
BPWM
833
Badgley Phelps Wealth Managers
Washington
$320K -$10.5K -148 -4%
HTHT
834
Hemenway Trust Hemenway Trust
New Hampshire
$319K – – –
FC
835
FCA Corp
Texas
$318K – – –
NME
836
Notis-McConarty Edward
$318K – – –
KFI
837
Key Financial Inc
Pennsylvania
$317K – – –
HCM
838
Howland Capital Management
Massachusetts
$317K -$60.8K -858 -18%
TAM
839
Titleist Asset Management
Texas
$317K +$282K +3,980 New
AWA
840
Arkadios Wealth Advisors
Georgia
$315K +$35.3K +498 +14%
HPC
841
HM Payson & Co
Maine
$315K +$1.99K +28 +0.7%
STA
842
Summit Trail Advisors
New York
$311K +$275K +3,882 New
MCCA
843
Mill Creek Capital Advisors
Pennsylvania
$309K – – –
FHA
844
First Horizon Advisors
Tennessee
$309K -$50.2K -708 -15%
APG
845
Abacus Planning Group
South Carolina
$308K +$275K +3,876 New
RCA
846
Resonant Capital Advisors
Wisconsin
$305K – – –
CSPIA
847
Cary Street Partners Investment Advisory
Virginia
$303K -$3.4K -48 -1%
FNBOH
848
First National Bank of Hutchinson
Kansas
$302K -$138K -1,946 -34%
BSW
849
Buckingham Strategic Wealth
Missouri
$302K – – –
MHR
850
Matthew Hamilton Rosenberg
$300K – – –
32 33
34
35 36

NVO Hedge Fund Activity: Q1 2023 in Review

1,146 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q1 2023, worth a combined $22.1B — up 15% from $19.3B a quarter earlier.

Buyers outnumbered sellers: 175 funds opened new NVO positions and 54 closed out — a net gain of 121 holders — while 327 added to existing stakes and 428 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $504M. The largest seller was Capital International Investors, cutting an estimated $360M.

  • 1,146 institutional investors held Novo Nordisk (NVO) as of Q1 2023, up from 1,049 in Q4 2022.
  • Funds reported $22.1B of Novo Nordisk stock for Q1 2023, up 15% quarter-over-quarter.
  • 175 funds opened new Novo Nordisk positions in Q1 2023 and 54 closed out, a net change of +121 holders.
  • The largest Novo Nordisk buyer in Q1 2023 was T. Rowe Price Associates, an estimated $504M added.
  • The largest Novo Nordisk seller in Q1 2023 was Capital International Investors, an estimated $360M sold.

Based on aggregated 13F filings for Q1 2023.